IFNA2 and chronic myelogenous leukemia, BCR-ABL1 positive: Interferon alpha 2a is a recombinant biological agent that is used for the treatment of several diseases including chronic hepatitis C, hairy cell leukemia, Philadelphia chromosome positive chronic myelogenous leukemia (CML) and AIDS-related Kaposi’s sarcoma.